Reassessment of declines in pulmonary function ≥ 1 year after stereotactic body radiotherapy

Chest

Volumn 143, Issue 1, 2013, Pages 130-137

  Takeda, Atsuya ^a,b   Enomoto, Tatsuji ^b   Sanuki, Naoko ^a   Handa, Hiroshi ^a   Aoki, Yousuke ^a   Oku, Yohei ^a   Kunieda, Etsuo ^c  

^a Ofuna Chuo Hospital   (Japan)

^b TOKYO METROPOLITAN HIROO HOSPITAL   (Japan)

^c TOKAI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG DISEASE; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG TUMOR; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE; RETROSPECTIVE STUDY; STEREOTACTIC BODY RADIATION THERAPY;

EID: 84871991110     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-0207     Document Type: Article

References (24)

1. Nguyen NP, Garland L, Welsh J, Hamilton R, Cohen D, Vinh-Hung V. Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma. Cancer Treat Rev. 2008;34(8):719-727.
2. Videtic GM, Stephans KL. The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient? Curr Oncol Rep. 2010;12(4):235-241.
3. Ohashi T, Takeda A, Shigematsu N, et al. Differences in pulmonary function before vs. 1 year after hypofractionated stereotactic radiotherapy for small peripheral lung tumors. Int J Radiat Oncol Biol Phys. 2005;62(4):1003- 1008. (Pubitemid 40884410)
4. Rabe KF, Hurd S, Anzueto A, et al Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532-555. (Pubitemid 47403272)
5. Takeda A, Kunieda E, Ohashi T, et al. Severe COPD is correlated with mild radiation pneumonitis following stereotactic body radiotherapy. Chest. 2012;141(4):858-866.
6. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24(30):4833-4839. (Pubitemid 46630909)
7. Takeda A, Kunieda E, Shigematsu N, et al. Small lung tumors: long-scan-time CT for planning of hypofractionated stereotactic radiation therapy - initial findings. Radiology. 2005;237(1):295-300. (Pubitemid 41346177)
8. Takeda A, Kunieda E, Sanuki N, et al. Dose distribution analysis in stereotactic body radiotherapy using dynamic conformal multiple arc therapy. Int J Radiat Oncol Biol Phys. 2009;74(2):363-369.
9. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152(3):1107-1136.
10. Japanese Respiratory Society. Predicted values of spirometry and arterial blood gas analysis in Japanese. J Jpn Resp Soc. 2001;39:1-17.
11. Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest. 2003;124(5):1946-1955. (Pubitemid 37433596)
12. Bishawi M, Kim B, Moore WH, Bilfinger TV. Pulmonary function testing after stereotactic body radiotherapy to the lung. Int J Radiat Oncol Biol Phys. 2012;82(1):e107-e110.
13. Stephans KL, Djemil T, Reddy CA, et al. Comprehensive analysis of pulmonary function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients. J Thorac Oncol. 2009;4(7):838-844.
14. Colice GL, Shafazand S, Griffin JP, et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007;132(suppl 4):161S-177S (Pubitemid 47502806)
15. Brunelli A, Charloux A, Bolliger CT, et al; European Respiratory Society and European Society of Thoracic Surgeons joint task force on fitness for radical therapy. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J. 2009;34(1):17-41.
16. Olsen GN, Block AJ, Swenson EW, Castle JR, Wynne JW. Pulmonary function evaluation of the lung resection candidate: a prospective study. Am Rev Respir Dis. 1975;111(4):379-387.
17. Markos J, Mullan BP, Hillman DR, et al. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis. 1989;139(4):902-910. (Pubitemid 19094312)
18. Wahi R, McMurtrey MJ, DeCaro LF, et al. Determinants of perioperative morbidity and mortality after pneumonectomy. Ann Thorac Surg. 1989;48(1):33-37. (Pubitemid 19213522)
19. Putnam JB Jr, Lammermeier DE, Colon R, McMurtrey MJ, Ali MK, Roth JA. Predicted pulmonary function and survival after pneumonectomy for primary lung carcinoma. Ann Thorac Surg. 1990;49(6):909-914.
20. Magdeleinat P, Seguin A, Alifano M, Boubia S, Regnard JF. Early and long-term results of lung resection for non-small-cell lung cancer in patients with severe ventilatory impairment. Eur J Cardiothorac Surg. 2005;27(6):1099-1105. (Pubitemid 40719593)
21. Palma D, Lagerwaard F, Rodrigues G, Haasbeek C, Senan S. Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review. Int J Radiat Oncol Biol Phys. 2012;82(3):1149-1156.
22. Harik-Khan RI, Fleg JL, Wise RA. Body mass index and the risk of COPD. Chest. 2002;121(2):370-376. (Pubitemid 34132971)
23. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(6):1856-1861. (Pubitemid 30004687)
24. Gold WM. Pulmonary Function Testing. In: Mason RJ, Broaddus VC, Murray JF, et al, eds. Murray and Nadel's Textbook of Respiratory Medicine. Philadelphia, PA: Elsevier Saunders; 2005:671-740.